Fluorescence in situ hybridization-based detection of mouse double minute 2 homolog amplification in dedifferentiated liposarcoma: A molecular cytogenetic case study
Year: 2026
Type: article
Abstract: About 20% of all soft tissue sarcomas are liposarcomas (LSs). Approximately 10% of these progress to dedifferentiated liposarcoma (DDLPS). When exhibiting heterologous differentiation, it can mimic high-grade sarcomas such as myxofibrosarcoma, rhabdomyosarcoma, chondrosarcoma, undifferentiated pleomorphic sarcoma, and even osteosarcoma. DDLPS has a more favorable prognosis than other high-grade sarcomas. Concerning clinical outcome, diagnostic accuracy becomes crucial. The mouse double minute 2 homolog (MDM2)/cyclin-dependent kinase 4 (CDK4) locus is amplified genomically in most of the cases of dedifferentiated LS. A systematic, stepwise histopathology-based immunohistochemical and MDM2/CDK4 fluorescence in situ hybridization (FISH) approach may facilitate the detection of genomic amplification, which could help differentiate DDLPS from other soft tissue neoplasia. FISH-based MDM2 amplification is currently the gold standard for diagnosing DDLPS. Here, we present the clinicopathological findings of a diagnostically challenging case of recurrent retroperitoneal mass in a 65-year-old female. Based on cytogenetic and histomorphological findings, the tumor was determined to be a case of DDLPS. Unfortunately, the patient succumbed to her illness after resection of the abdominal mass. The study highlights the relevance of a strategy-based, cost-effective, and rapid FISH screening approach in the context of relevant clinical and histopathological settings.
Source: Journal of Laboratory Physicians
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $200
OpenAlex ID: W7237344807
